吉林大学学报(医学版) ›› 2019, Vol. 45 ›› Issue (03): 709-713.doi: 10.13481/j.1671-587x.20190342

• 临床医学 • 上一篇    

以下丘脑症状起病的抗LGI1抗体阳性边缘叶脑炎1例报告及文献复习

刘洋1, 刘志2, 金嘉慧2, 赵洋洋2, 马历兵2, 张国2, 刘文革3, 任俊2, 李凤娥4, 孔繁利1   

  1. 1. 北华大学基础医学院病理生理学教研室, 吉林 吉林 132021;
    2. 吉林省吉林市中心医院神经科, 吉林 吉林 132011;
    3. 吉林省吉林市中心医院ICU科, 吉林 吉林 132011;
    4. 北华大学附属医院神经二科, 吉林 吉林 132013
  • 收稿日期:2018-09-06 发布日期:2019-06-05
  • 通讯作者: 刘志,副教授(Tel:0432-63073089,E-mail:lzsky7@outlook.com);孔繁利,教授,硕士研究生导师(Tel:0432-64608598,E-mail:kongfanli5@163.com) E-mail:lzsky7@outlook.com;kongfanli5@163.com
  • 作者简介:刘洋(1975-),女,吉林省吉林市人,讲师,医学博士,主要从事超声和神经变性疾病方面的研究。
  • 基金资助:
    吉林省教育厅"十三五"科技项目资助课题(JJKH20180352KJ,JJKH20180354KJ);吉林省卫计委卫生技术创新项目资助课题(2017J086);吉林省卫计委中医药科技项目资助课题(2017083)

Anti-LGI1 antibody positive limbic encephalitis presenting hypothalamus symptoms: A case report and literature review

LIU Yang1, LIU Zhi2, JIN Jiahui2, ZHAO Yangyang2, MA Libing2, ZHANG Guo2, LIU Wenge3, REN Jun2, LI Fenge4, KONG Fanli1   

  1. 1. Department of Pathophysiology, School of Basic Medical Sciences, Beihua University, Jilin 132021, China;
    2. Department of Neurology, Central Hospital, Jilin City, Jilin Province, Jilin 132011, China;
    3. Department of ICU, Central Hospital, Jilin City, Jilin Province, Jilin 132011, China;
    4. Department of Neurology, Affiliated Hospital, Beihua University, Jilin 132013, China
  • Received:2018-09-06 Published:2019-06-05

摘要: 目的:探讨抗富亮氨酸胶质瘤失活1蛋白(LGI1)抗体阳性边缘叶脑炎(LE)的临床特点,为其临床诊治提供参考。方法:分析1例以下丘脑症状起病的抗LGI1抗体阳性LE患者的临床资料,并结合文献复习,总结LE患者的诊治方法。结果:患者入院前2个月出现性欲减退、过度进食、沉默寡言,日间多眠,间断大汗,无诱因发热,低钠血症,并间断出现遗忘及面-臂肌张力障碍发作(FBDS),症状逐渐加重,入院时简易智力状态检查量表(MMSE)评分为22分,不能配合蒙特利尔认知评估量表(MoCA)评估,血清抗LGI1抗体阳性(1∶100),脑脊液抗LGI1抗体阳性(1∶10)。头部MRI示双侧海马、杏仁核和颞叶内侧T1低信号,T2、Flair高信号,DWI高信号;右侧尤其明显。临床诊断为抗LGI1抗体阳性LE,给予免疫球蛋白联合甲泼尼龙琥珀酸钠冲击治疗,全部症状消失,随访6个月,患者恢复正常。结论:患者血清与脑脊液抗LGI1抗体均呈阳性结合头部MRI结果可明确诊断抗LGI1抗体阳性LE。下丘脑症状、记忆障碍和FBDS均对免疫球蛋白联合肾上腺糖皮质激素冲击治疗反应良好,该病早期可能同时存在下丘脑损伤。

关键词: 边缘叶脑炎, 下丘脑, 面-臂肌张力障碍发作, 富亮氨酸胶质瘤失活1蛋白

Abstract: Objective:To study the clinical characteristics of eucine-rich glioma-inactivated1protein(LGI1) antibody positive limbic encephalitis (LE), and to provide the reference for its diagnosis and streatment. Methods:The clinical data of a patient with anti-LGI1 antibody positive LE who presented the hypothalamus symptoms was analyzed, the literature review was performed, and the diagnosis and treatment methods of the LE patients were summarized. Results:The patient showed the following symptoms 2 months before hospitalisation,such as sexual dysfunction,overeating, taciturnity, daytime hyposia, intermittent sweating, fever without inducement, hyponatremia, intermittent memory loss and faciobrachial dystonic seizure (FBDS), and the above symptoms progressively exacerbated. After hospitalization,the Mini-Mental State Examination(MMSE)score was 22;the patient could't finish the evaluation of Montreal Cognitive Assessment Scale(MoCA); the serum anti-LGI1 antibody was positive (1:100),and the cerebrospinal fluid anti-LGI1 antibody was positive(1:10). The MRI results showed T1 low signal, T2, Flair high signal, DWI high signal in bilateral hippocampus, amygdala and medial temporal lobe, especially in the right side. The patient was diagnosed as anti-LGI1 antibody positive LE, whose symptoms relieved rapidly after administration of immunoglobulin and steroid therapy. After 6- month-follow-up, the patient recovered completely. Conclusion:The positive results of serum and cerebrospinal fluid anti-LGI1 antibody in the patients combined with the MRI results of head can confirm the diagnosis of anti-LGI1 antibody positive LE. The hypothalamus symptoms, memory loss and FBDS are improved rapidly after immunoglobulin and steroid therapy. The hypothalamic injury possibly exist in the early-stage of anti-LGI1 antibody positive LE.

Key words: limbic encephalitis, hypothalamus, faciobrachial dystonic seizure, leucine-rich glioma-inactivated 1protein

中图分类号: 

  • R741.04